• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Emergent BioSolutions

Emergent BioSolutions

  1. TWi Biotechnology Receives Rare Disease Drug Designation for its Drug Candidate AC-203 in Taiwan

    TWi Biotechnology Receives Rare Disease Drug Designation for its Drug Candidate AC-203 in Taiwan

  2. TABB Group Analyzes Current State of SEC’s Consolidated Audit Trail (CAT) in First of Three-Part Research Series

    TABB Group Analyzes Current State of SEC’s Consolidated Audit Trail (CAT) in First of Three-Part Research Series

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.